Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking

  08 January 2020

Seattle-based startup Phase Genomics announced Tuesday it has received a two-year, $1.5 million grant from the National Institutes of Health to support the development of a rapid antimicrobial resistance tracking kit based on the firm’s proprietary high-throughput chromatin conformation, or Hi-C, proximity ligation technology.

The Phase II Small Business Innovation Research funds were awarded by the National Institute of Allergy and Infectious Diseases. The funding will support the development of a low-cost platform to detect antimicrobial resistance elements in microbial communities without the need for bacterial culture.

Further reading: Genome Web
Author(s): staff reporter
Smart Innovations  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!